Response to P.M. Ravdin (BCRT 24:219-226, 1993), ?Evaluation of cathepsin D as a prognostic factor in breast cancer?
- 1 January 1993
- journal article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 26 (1) , 107-111
- https://doi.org/10.1007/bf00682706
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Cathepsin D expression detected by immunohistochemistry has independent prognostic value in axillary node-negative breast cancer.Journal of Clinical Oncology, 1993
- Cathepsin D as a prognostic indicator for node-negative breast cancer patients using both immunoassays and enzymatic assays.1992
- Quality control of cathepsin-D measurement by the EORTC receptor study groupEuropean Journal Of Cancer, 1992
- Cathepsin D in breast cancer: A tissue marker associated with metastasisEuropean Journal Of Cancer, 1992
- Breast Cancer Prognostic Factors: Evaluation GuidelinesJNCI Journal of the National Cancer Institute, 1991
- Cathepsin D assay in primary breast cancer and lymph nodes: Relationship with c-myc, c-erb-B-2 and int-2 oncogene amplification and node invasivenessEuropean Journal of Cancer and Clinical Oncology, 1990
- Cathepsin D and Prognosis in Breast CancerNew England Journal of Medicine, 1990
- ASSOCIATION BETWEEN HIGH-CONCENTRATIONS OF MR 52,000 CATHEPSIN-D AND POOR PROGNOSIS IN PRIMARY HUMAN-BREAST CANCER1989
- CATHEPSIN D: AN INDEPENDENT PROGNOSTIC FACTOR FOR METASTASIS OF BREAST CANCERThe Lancet, 1989
- Two-site immunoenzymometric assay for the 52-kDa cathepsin D in cytosols of breast cancer tissues.Clinical Chemistry, 1989